KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 99 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,156,503 | -9.0% | 124,151 | -26.2% | 0.00% | -50.0% |
| Q2 2023 | $2,370,030 | -33.9% | 168,326 | -49.5% | 0.00% | -33.3% |
| Q1 2023 | $3,586,964 | -5.4% | 333,361 | +31.7% | 0.00% | 0.0% |
| Q4 2022 | $3,791,558 | +311.2% | 253,108 | +252.1% | 0.00% | – |
| Q3 2022 | $922,000 | +1948.9% | 71,878 | +1448.8% | 0.00% | – |
| Q2 2022 | $45,000 | +55.2% | 4,641 | +62.2% | 0.00% | – |
| Q1 2022 | $29,000 | -96.7% | 2,861 | -96.1% | 0.00% | – |
| Q4 2021 | $869,000 | +28.9% | 73,826 | +24.8% | 0.00% | – |
| Q3 2021 | $674,000 | -69.6% | 59,170 | -62.8% | 0.00% | -100.0% |
| Q2 2021 | $2,214,000 | -12.7% | 158,955 | +16.0% | 0.00% | -50.0% |
| Q1 2021 | $2,537,000 | +2106.1% | 137,061 | +2007.0% | 0.00% | – |
| Q4 2020 | $115,000 | +379.2% | 6,505 | +316.7% | 0.00% | – |
| Q3 2020 | $24,000 | -83.4% | 1,561 | -72.6% | 0.00% | – |
| Q2 2020 | $145,000 | +137.7% | 5,691 | +44.2% | 0.00% | – |
| Q1 2020 | $61,000 | +96.8% | 3,946 | +41.1% | 0.00% | – |
| Q4 2019 | $31,000 | +210.0% | 2,797 | +138.2% | 0.00% | – |
| Q3 2019 | $10,000 | -82.8% | 1,174 | -72.9% | 0.00% | – |
| Q2 2019 | $58,000 | -6.5% | 4,326 | +26.3% | 0.00% | – |
| Q1 2019 | $62,000 | +55.0% | 3,426 | +145.9% | 0.00% | – |
| Q4 2018 | $40,000 | -16.7% | 1,393 | -26.1% | 0.00% | – |
| Q3 2018 | $48,000 | – | 1,885 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |